Jpmorgan Chase & CO Form 4 insider transactions

Stacey Friedman, General Counsel of JPMorgan Chase, reports the acquisition of 42,190.8691 Performance Share Units (PSUs) based on the firm's performance, set to vest and settle on March 25, 2025.

Mary Erdoes, CEO of Asset & Wealth Management at JPMorgan Chase, disposed of preferred stock and acquired performance share units, according to a recent SEC filing.

JPMorgan Chase's Chief Financial Officer, Jeremy Barnum, was awarded 29,632.5953 Performance Share Units (PSUs) based on the firm's performance over a three-year period.

James Dimon, Chairman & CEO of JPMorgan Chase & Co., was granted 297,186 Performance Share Units (PSUs) based on the firm's performance over a three-year period.

Lori A. Beer, Chief Information Officer of JPMorgan Chase & Co, reports the acquisition of performance share units (PSUs) convertible to common stock based on the firm's performance.

Ashley Bacon, Chief Risk Officer of JPMorgan Chase, reports the acquisition of 42,190.8691 Performance Share Units (PSUs) based on the firm's performance.

Troy Rohrbaugh, Co-CEO of CIB at JPMorgan Chase & Co, sold 37,500 shares of common stock on February 20, 2025, at a price of $269.8365 per share.

Lori A. Beer, Chief Information Officer of JPMorgan Chase & Co, reported selling 2,053 shares of common stock on February 20, 2025.

Jennifer Piepszak, Chief Operating Officer of JPMorgan Chase & Co, sold 4,273 shares of common stock on February 20, 2025.

Robin Leopold, Head of Human Resources at JPMorgan Chase, reported the sale of 1,250 shares of common stock on February 20, 2025.

James Dimon, Chairman and CEO of JPMorgan Chase & Co, sold a significant number of shares on February 20, 2025, according to a recent SEC filing.

Mary Erdoes, CEO of Asset & Wealth Management at JPMorgan Chase, reported the sale of 5,277 shares of common stock on February 18, 2025.

Douglas Petno, Co-CEO of CIB at JPMorgan Chase & Co, sold 3,490 shares of common stock on February 18, 2025.

Stacey Friedman, General Counsel of JPMorgan Chase, reported the sale of 3,303 shares of common stock on February 18, 2025.

Marianne Lake, CEO of Commercial & Consumer Banking at JPMorgan Chase, sold 4,232 shares of common stock at a price of $278.3576 on February 18, 2025.

Robin Leopold, Head of Human Resources at JPMorgan Chase, reported the transfer of common stock shares from spouse's and grantor retained annuity trusts on February 10, 2025.

James Dimon, Chairman & CEO of JPMorgan Chase & Co., filed a Form 4 disclosing changes in his beneficial ownership of the company's stock due to a gift to a non-profit and transfers from Grantor Retained Annuity Trusts (GRATs).

Mark Weinberger, a director at JPMorgan Chase & Co., acquired 1,011.9262 shares of common stock on January 21, 2025, through a deferral of his annual stock grant, payable upon termination of service.

Director Brad D. Smith reports acquisition of JPMorgan Chase & Co. stock due to deferral of annual stock grant.

Director Virginia Rometty acquired 1,011.9262 shares of JPMorgan Chase & Co. stock on January 21, 2025, through a deferral of her annual stock grant.

Director Phebe Novakovic acquired 1,011.9262 shares of JPMorgan Chase & Co. common stock on January 21, 2025, through a deferred stock grant.

Mellody Hobson, a director at JPMorgan Chase & Co, reports acquiring shares of common stock through a deferral of an annual stock grant.

Director Alex Gorsky reports acquisition of 1,011.9262 shares of JPMorgan Chase & Co. common stock at $261.8768 per share due to deferral of annual stock grant.

Alicia Boler-Davis, a director at JPMorgan Chase & Co., received a deferred stock grant payable upon termination of service, as disclosed in a recent SEC Form 4 filing.

Director Todd A. Combs acquired 1,011.9262 shares of JPMorgan Chase & Co. common stock on January 21, 2025, through a deferred annual stock grant.

Director Stephen B. Burke reports acquisition of JPMorgan Chase & Co. stock through deferred compensation and holdings in a trust.

Director Linda Bammann acquired 1,011.9262 shares of JPMorgan Chase & Co. common stock on January 21, 2025, through a deferral of her annual stock grant.

Elena A. Korablina, Corporate Controller of JPMorgan Chase & Co, reports the acquisition of 8,783 Restricted Stock Units (RSUs) on January 21, 2025, which vest in two tranches in 2027 and 2028.

Douglas Petno, Co-CEO of CIB at JPMorgan Chase, reports the acquisition of restricted stock units (RSUs) as part of his equity-based incentive compensation for the 2024 performance year.

Troy Rohrbaugh, Co-CEO of CIB at JPMorgan Chase, reports the acquisition of 26,349 Restricted Stock Units (RSUs) as part of equity-based incentive compensation.